Similar articles

• Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.

  Dittmer U, Brooks DM, Hasenkrug KJ. Dittmer U, et al. J Virol. 1998 Aug;72(8):6554-8. doi: 10.1128/JVI.72.8.6554-6558.1998. J Virol. 1998. PMID: 9658099 Free PMC article.
• The envelopes of two ecotropic murine leukemia viruses display distinct efficiencies in retroviral vaccination by interference.

  Corbin A, Richardson J, Denesvre C, Pozo F, Ellerbrok H, Sitbon M. Corbin A, et al. Virology. 1994 Jul;202(1):70-5. doi: 10.1006/viro.1994.1323. Virology. 1994. PMID: 8009868
• Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses.

  Corbin A, Sitbon M. Corbin A, et al. J Virol. 1993 Sep;67(9):5146-52. doi: 10.1128/JVI.67.9.5146-5152.1993. J Virol. 1993. PMID: 8394442 Free PMC article.
• The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model.

  Hasenkrug KJ, Dittmer U. Hasenkrug KJ, et al. Virology. 2000 Jul 5;272(2):244-9. doi: 10.1006/viro.2000.0387. Virology. 2000. PMID: 10873767 Review. No abstract available.
• Efficacy of recombinant feline leukemia virus vaccines.

  Jarrett O. Jarrett O. AIDS Res Hum Retroviruses. 1996 Mar 20;12(5):435-6. doi: 10.1089/aid.1996.12.435. AIDS Res Hum Retroviruses. 1996. PMID: 8882328 Review. No abstract available.